Picture of Aytu Biopharma logo

AYTU — Aytu Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Aytu Biopharma Announces Agreement With Avenue Venture Debt Fund To Extend Interest-Only Period Of Company’S Term Loan

Oct 25 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA ANNOUNCES AGREEMENT WITH AVENUE VENTURE
DEBT FUND
TO EXTEND INTEREST-ONLY PERIOD OF COMPANY’S TERM LOAN
    * AYTU BIOPHARMA INC - AMENDMENT DEFERS OVER $3 MILLION IN
PRINCIPAL PAYMENTS BEYOND 2023
    * AYTU BIOPHARMA INC - AMENDMENT OF SECURED LOAN AGREEMENT
EXTENDS
INTEREST-ONLY PERIOD TO JANUARY 2024
    * AYTU BIOPHARMA - MATURITY DATE OF LOAN IS JAN 2025 AND IS
SUBJECT TO ADDITIONAL INTEREST-ONLY PERIOD EXTENSIONS UPON
ACHIEVEMENT OF MILESTONES BY CO
    * AYTU BIOPHARMA - UNDER AMMENDMENT, CO & AVENUE AGREED TO
RESET
EXERCISE PRICE OF WARRANTS ISSUED IN RELATION WITH ORIGINAL LOAN
AGREEMENT TO $0.43

Further company coverage:  AYTU.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Aytu Biopharma

See all news